UPDATE 1-Dendreon Q3 loss widens

Fri Nov 7, 2008 8:19am EST
 
[-] Text [+]

* Q3 loss widens

* Revenue down 77 pct

Nov 7 (Reuters) - Biotechnology company Dendreon Corp (DNDN.O) posted a wider third-quarter loss, hurt by a drop in sales.

The company posted a net loss of $26.8 million, compared with a net loss of $19.2 million, in the year-ago quarter. Third-quarter revenue fell to $26,000.

Dendreon said latest-quarter results include a non-cash charge of $9.1 million.

However, total operating expenses for the quarter fell 13 percent to $17.3 million.

The company also said it received net proceeds of $19.8 million relating to a draw down on its equity line of credit with Azimuth Opportunity Ltd.

Shares of the company closed at $5.08 Thursday, on Nasdaq. For the alerts, please double click [ID:nWNAB0119]. For the company press release, please double click [ID:nPnAQF512a] (Reporting by Vidya L Nathan in Bangalore; Editing by Amitha Rajan)

 

Companies In This Article

Join the Reuters Consumer Insight Panel and help us get to know you better

Join the Reuters Consumer Insight Panel and help us get to know you better